1. Is it Time for Reporting Guidelines for Calibration Methods?

   • Scott B. Cantor

   Commentary 17 September 2012 Pages: 529 - 531

2. Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

   • Natasha K. Stout
   • Amy B. Knudsen
   • G. Scott Gazelle

   Review Article 17 September 2012 Pages: 533 - 545

   

3. Societal and Patient Burden of Fibromyalgia Syndrome

   • Lieven Annemans
   • Katell Le Lay
   • Charles Taïeb

   Review Article 17 September 2012 Pages: 547 - 559

   

4. Economic Evaluations in the EURONHEED

   • Florencia Hutter
   • Fernando Antoñanzas

   Review Article 17 September 2012 Pages: 561 - 570

   

5. Costs of Illness in a Russian Cohort of Patients with Parkinson’s Disease

   • Yaroslav Winter
   • Sonja von Campenhausen
   • Alla Guekht

   Original Research Article 17 September 2012 Pages: 571 - 584

   

6. Cost Effectiveness of Fondaparinux in Non-ST-Elevation Acute Coronary Syndrome

   • Jaime Latour-Perez
   • Eva de-Miguel-Balsa

   Original Research Article 17 September 2012 Pages: 585 - 595

   

7. Cost-Effectiveness Analysis of Capecitabine Compared with Bolus 5-Fluorouracil/l-Leucovorin for the Adjuvant Treatment of Colon Cancer in Japan

   • Takeru Shiroiwa
   • Takashi Fukuda
   • Kiichiro Tsutani

   Original Research Article 17 September 2012 Pages: 597 - 608

   

8. Cost Utility of Adalimumab versus Infliximab Maintenance Therapies in the United States for Moderately to Severely Active Crohn’s Disease

   • Andrew P. Yu
   • Scott Johnson
   • Parvez M. Mulani

   Original Research Article 17 September 2012 Pages: 609 - 621